Skip to content

Liver safety analysis of Samsamani Vati/ Giloya ghana vati .

A prospective randomized hepatic safety analysis of subjects used samshamani vati / guduchi ghana vati in prevention of covid-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/06/043050
Enrollment
30
Registered
2022-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

JSS Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The subjects included in the analysis of irrespective sex in between the age 20 years to 60 years those have no disease. The subjects are Willing to come for regular follow up visits will be included in the study.

Exclusion criteria

Exclusion criteria: The subjects having severe liver, kidney and heart diseases are excluded in the study. Patients who are currently participating in any other clinical trial. Subject with history of alcohol consumption > than 20 gm/week and/or drug abuse Known allergy, sensitivity or intolerance to the study drugs and their formulation ingredients are excluded in the study. Any condition that in the opinion of the investigator does not justify the patientââ?¬•s inclusion for the study.

Design outcomes

Secondary

MeasureTime frame
The secondary outcome is to detect the patient condition, morbid factors, gravity of liver injury of subjects, policy for de-challenge the medication and dose if Guduchi ghana vati Induced Liver Injury will be notedTimepoint: 02 months

Primary

MeasureTime frame
The primary outcome intended to create data base of the hepatic safety and address the evidence of Guduchi ghana vati Induced Liver Injury if occurredTimepoint: 2 months

Countries

India

Contacts

Public ContactAshok Kumar Panda

CCRAS, New Delhi

akpanda_06@yahoo.co.in07044081670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026